These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37021924)

  • 1. Psychiatric disorders and anger in patients with controlled acromegaly.
    Prencipe N; Motta G; Crespi CM; Albert U; Berton AM; Bona C; Bioletto F; Varaldo E; Cuboni D; Gasco V; Ghigo E; Maina G; Grottoli S
    Minerva Endocrinol (Torino); 2023 Apr; ():. PubMed ID: 37021924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study.
    Sardella C; Lombardi M; Rossi G; Cosci C; Brogioni S; Scattina I; Webb SM; Gasperi M; Martino E; Bogazzi F
    J Endocrinol Invest; 2010 Jan; 33(1):20-5. PubMed ID: 20203538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies.
    Fleseriu M; Fogelfeld L; Gordon MB; Sisco J; Crosby RD; Ludlam WH; Haviv A; Mathias SD
    Pituitary; 2020 Aug; 23(4):347-358. PubMed ID: 32221764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly.
    van der Klaauw AA; Biermasz NR; Hoftijzer HC; Pereira AM; Romijn JA
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):123-8. PubMed ID: 18182092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study.
    Alito A; Basile GC; Bruschetta D; Berescu GL; Cavallaro F; Postorino AD; Scarcella E; Ragonese M; Cannavò S; Tisano A
    Folia Med (Plovdiv); 2023 Feb; 65(1):37-45. PubMed ID: 36855972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between paraclinical parameters, symptoms and quality of life in patients with acromegaly: a cross sectional study.
    Gliga MC; Reti Z; Gliga C; Pascanu IM
    J Patient Rep Outcomes; 2022 Dec; 6(1):130. PubMed ID: 36577870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid vascularity is increased in patients with active acromegaly.
    Bogazzi F; Manetti L; Bartalena L; Gasperi M; Grasso L; Cecconi E; Rago T; Pinchera A; Martino E
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):65-70. PubMed ID: 12100071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study.
    Gagliardi I; Chiloiro S; Vallillo M; Bondanelli M; Volpato S; Giampietro A; Bianchi A; De Marinis L; Zatelli MC; Ambrosio MR
    BMC Geriatr; 2021 Oct; 21(1):598. PubMed ID: 34702173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.
    Caron PJ; Bevan JS; Petersenn S; Houchard A; Sert C; Webb SM;
    Pituitary; 2016 Apr; 19(2):149-57. PubMed ID: 26603536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Submandibular salivary gland volume is increased in patients with acromegaly.
    Manetti L; Bogazzi F; Brogioni S; Grasso L; Lupi I; Genovesi M; Cecconi E; Gasperi M; Martino E
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):97-100. PubMed ID: 12100076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?
    Chiloiro S; Giampietro A; Gagliardi I; Bondanelli M; Epifani V; Milardi D; Ambrosio MR; Zatelli MC; Pontecorvi A; De Marinis L; Bianchi A
    Endocrine; 2023 Apr; 80(1):142-151. PubMed ID: 36447087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegaly.
    Grottoli S; Gasco V; Mainolfi A; Beccuti G; Corneli G; Aimaretti G; Dieguez C; Casanueva F; Ghigo E
    J Endocrinol Invest; 2008 Dec; 31(12):1103-9. PubMed ID: 19246978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in female patients with acromegaly.
    Celik O; Kadioglu P
    J Endocrinol Invest; 2013 Jun; 36(6):412-6. PubMed ID: 23211278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
    Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
    Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas.
    Vega-Beyhart A; Enriquez-Estrada VM; Bello-Chavolla OY; Torres-Victoria TR; Martínez-Sánchez FD; López-Navarro JM; Pérez-Guzmán MC; Hinojosa-Amaya JM; León-Suárez A; Espinoza-Salazar HD; Roldán-Sarmiento P; Gómez-Sámano MA; Gómez-Pérez FJ; Cuevas-Ramos D
    Clin Endocrinol (Oxf); 2019 Mar; 90(3):457-467. PubMed ID: 30548674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up.
    Guaraldi F; Gori D; Beccuti G; Prencipe N; Giordano R; Mints Y; Di Giacomo VS; Berton A; Lorente M; Gasco V; Ghigo E; Salvatori R; Grottoli S
    J Endocrinol Invest; 2016 Nov; 39(11):1277-1284. PubMed ID: 27153851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.
    Matta MP; Couture E; Cazals L; Vezzosi D; Bennet A; Caron P
    Eur J Endocrinol; 2008 Mar; 158(3):305-10. PubMed ID: 18299462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?
    Anagnostis P; Efstathiadou ZA; Charizopoulou M; Selalmatzidou D; Karathanasi E; Poulasouchidou M; Kita M
    Endocrine; 2014 Nov; 47(2):564-71. PubMed ID: 24510628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.